Alzamend Neuro, Inc. (ALZN)
NASDAQ: ALZN · Real-Time Price · USD
2.420
-0.020 (-0.82%)
At close: Aug 13, 2025, 4:00 PM
2.500
+0.080 (3.31%)
Pre-market: Aug 14, 2025, 9:03 AM EDT
Alzamend Neuro Market Cap
Alzamend Neuro has a market cap or net worth of $7.60 million as of August 14, 2025. Its market cap has increased by 149.86% in one year.
Market Cap
7.60M
Enterprise Value
3.65M
1-Year Change
149.86%
Ranking
Category
Stock Price
$2.42
Market Cap Chart
Since the IPO on June 15, 2021, Alzamend Neuro's market cap has decreased from $1.15B to $7.60M, a decrease of -99.34%. That is a compound annual growth rate of -70.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 7.66M | 21.57% |
| Dec 31, 2024 | 6.30M | -0.56% |
| Dec 29, 2023 | 6.34M | -88.37% |
| Dec 30, 2022 | 54.47M | -67.73% |
| Dec 31, 2021 | 168.82M | -85.28% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 570.26B |
| Johnson & Johnson | 418.62B |
| AbbVie | 350.91B |
| AstraZeneca | 229.47B |
| UnitedHealth Group | 228.94B |
| Novartis AG | 228.69B |
| Abbott Laboratories | 228.63B |
| Novo Nordisk | 222.88B |